(Last updated: January 12, 2018)
The National Health Information Sharing and Analysis Center (NH-ISAC) has issued an advisory to the industry regarding Meltdown and Spectre, two new widespread cybersecurity vulnerabilities impacting processors in nearly every computer and mobile device.
Abbott is actively monitoring updates related to these vulnerabilities and is working to ensure the continued security and integrity of all our infrastructure, systems and products.
At this time, we have received no reports of compromise to any Abbott systems or products resulting from these vulnerabilities. Abbott is committed to ensuring the safety, security, integrity and regulatory compliance of our products. Our team continues to evaluate any potential impact these vulnerabilities may have on individual products, and we will notify customers if there are additional actions or recommendations related to Abbott products.
Abbott’s information security team also is testing vendor patches for effectiveness and potential impact to Abbott systems.
Customers with additional product or site-specific concerns should contact their Abbott sales or service representative.
More background on Meltdown and Spectre can be found HERE.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
FOLLOW ABBOTT